APA (7th ed.) Citation

S, M., A, G., S, P., A, G., N, J., A, C., . . . N, K. (2026). Is Less "Sufficient" and "Safe" in the MRD Era - Outcomes of Autologous Stem-Cell Transplant as per Melphalan Dose in Patients with Multiple Myeloma. Blood cancer journal, 16(1), 10. https://doi.org/10.1038/s41408-025-01437-z

Chicago Style (17th ed.) Citation

S, Mirgh, et al. "Is Less "Sufficient" and "Safe" in the MRD Era - Outcomes of Autologous Stem-Cell Transplant as Per Melphalan Dose in Patients with Multiple Myeloma." Blood Cancer Journal 16, no. 1 (2026): 10. https://doi.org/10.1038/s41408-025-01437-z.

MLA (9th ed.) Citation

S, Mirgh, et al. "Is Less "Sufficient" and "Safe" in the MRD Era - Outcomes of Autologous Stem-Cell Transplant as Per Melphalan Dose in Patients with Multiple Myeloma." Blood Cancer Journal, vol. 16, no. 1, 2026, p. 10, https://doi.org/10.1038/s41408-025-01437-z.